Related references
Note: Only part of the references are listed.Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview
P. Lacombe et al.
Diagnostic and Interventional Imaging (2013)
Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 (ALK1) Mutation
Barbara Girerd et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
TGF-beta and BMPR-II pharmacology-implications for pulmonary vascular diseases
Paul D. Upton et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
BMPR2 Mutation in a Patient With Pulmonary Arterial Hypertension and Suspected Hereditary Hemorrhagic Telangiectasia
Christina M. Rigelsky et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Mutations of the TGF-β type II receptor BMPR2 in pulmonary arterial hypertension
RD Machado et al.
HUMAN MUTATION (2006)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
Share Paper
